文献速递产科母胎医学

俄亥俄州全州孕激素推广项目

A Statewide Progestogen Promotion Program in Ohio.
PubMed 文献 · Obstet Gynecol · 2017-01-01

俄亥俄州围产质量协作组于2014年启动质量改进项目,与20家大型产科医院等合作,通过质量改进方法识别合格孕妇并消除治疗障碍。项目追踪了2562名合格女性,调整风险因素后,与项目相关的既往早产女性32周前单胎分娩减少13%(95%CI 0.3-24%)。

要点

  • 项目覆盖20家大型产科医院,追踪2562名合格女性,旨在将俄亥俄州早产减少10%。
  • 调整风险因素后,既往早产女性32周前分娩与项目相关减少13%(95%CI 0.3-24%)。
  • 所有医院32周前分娩减少6.6%,参与医院减少8.0%;37周前分娩受影响极小。

核心结论

  • 俄亥俄州孕激素项目与俄亥俄州32周前单胎分娩的持续减少相关。

研究设计与样本

  • 俄亥俄州围产质量协作组于2014年启动质量改进项目,与20家大型产科医院诊所、俄亥俄州医疗补助(Medicaid)、Medicaid保险公司及服务机构合作。
  • 参与点位于2014年1月1日至2015年11月30日追踪了2562名合格治疗女性。
  • 采用统计过程控制方法分析变化,并用广义线性混合模型估计项目效应,调整已知风险因素。

主要发现

  • 所有医院32周前分娩减少6.6%,参与医院减少8.0%。
  • 既往早产女性32周前分娩在所有医院减少20.5%,非洲裔美国女性减少20.3%,Medicaid女性减少17.1%。
  • 37周前分娩受影响极小。
  • 调整风险因素和医院分娩聚集后,确认与项目相关的既往早产女性32周前分娩减少13%(95%CI 0.3-24%)。

关键数值与推荐

  • 合格女性在妊娠20周和24周前接受孕激素处方的百分比及遇到的障碍每月报告。
  • 诊所被要求采用方案识别候选者并立即启动治疗。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To promote use of progestogen therapy to reduce premature births in Ohio by 10%. METHODS: The Ohio Perinatal Quality Collaborative initiated a quality improvement project in 2014 working with clinics at 20 large maternity hospitals, Ohio Medicaid, Medicaid insurers, and service agencies to use quality improvement methods to identify eligible women and remove treatment barriers. The number of women eligible for prophylaxis, the percent prescribed a progestogen before 20 and 24 weeks of gestation, and barriers encountered were reported monthly. Clinics were asked to adopt protocols to identify candidates and initiate treatment promptly. System-level changes were made to expand Medicaid eligibility, maintain Medicaid coverage during pregnancy, improve communication, and adopt uniform data collection and efficient treatment protocols. Rates of singleton births before 32 and 37 weeks of gestation in Ohio hospitals were primary outcomes. We used statistical process control methods to analyze change and generalized linear mixed models to estimate program effects accounting for known risk factors. RESULTS: Participating sites tracked 2,562 women eligible for treatment between January 1, 2014, and November 30, 2015. Late entry to care, variable interpretation of treatment guidelines, maintenance of Medicaid coverage, and inefficient communication among health care providers and insurers were identified as treatment barriers. Births before 32 weeks of gestation decreased in all hospitals by 6.6% and in participating hospitals by 8.0%. Births before 32 weeks of gestation to women with prior preterm birth decreased by 20.5% in all hospitals, by 20.3% in African American women, and by 17.1% in women on Medicaid. Births before 37 weeks of gestation were minimally affected. Adjusting for risk factors and birth clustering by hospital confirmed a program-associated 13% (95% confidence interval 0.3-24%) reduction in births before 32 weeks of gestation to women with prior preterm birth. CONCLUSION: The Ohio progestogen project was associated with a sustained reduction in singleton births before 32 weeks of gestation in Ohio.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Iams JD, Applegate MS, Marcotte MP, et al. A Statewide Progestogen Promotion Program in Ohio. Obstet Gynecol. 2017. PMID: 28079774. doi:10.1097/AOG.0000000000001841

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。